Moreover, VHL is mutated in 70% of ccRCC tumors and hypermethylated in 15% (3), and inactivating VHL mutation is considered the main driver of ccRCC carcinogenesis (4). The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.